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Objective: To examine the effect of case management on glycemic control and behavioral outcomes in
adults with Type 2 diabetes in China.
Methods: Participants were randomly assigned to a 1-year case management (CM) group (n = 60) or
control group (n = 60). Monthly case management visits included identifying individuals’ diabetesrelated problems, setting goals, planning self-care, and evaluating progress. During a 1-year follow-up, all
participants attended visits every 3 months without intervention.
Results: In the CM vs. the control group, HbA1c was reduced at 6 months compared to baseline (P = 0.034),
with trends at 12 and 24 months, and empowerment ability improved (P < 0.05). Also in the CM vs.
controls, total self-care behaviors, the frequency of exercise, blood glucose testing, and foot care were
higher (P < 0.001) at 12 months, and the percentage of individuals with HbA1c 7.0% was higher
(P = 0.035) at 24 months.
Conclusion: The case management intervention in China was effective at 6 months and, based on trends in
HbA1c at 12 and 24 months and results for behavioral outcomes, the intervention shows promise and
warrants more research.
Practice implications: A case management approach can enhance behavior change and glycemic control in
Chinese with diabetes.
ã 2016 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Diabetes mellitus is reaching epidemic proportions globally;
1.3 million deaths resulted from diabetes in 2010 [1]. The global
prevalence of diabetes in adults is 8.3% (382 million people) [2]. In
China, the most populous country, the prevalence of diabetes is
high at 11.6% (affecting 113.9 million people) [3] compared to the
United States at 9.9% [4] and Europe at 8.1% [5]. Less than one-third
(30.1%) of Chinese diabetic patients are aware of their condition
[3]. Also in China, prediabetes is extremely high at 50.1% (affecting
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493.4 million people) [3], compared to the United States at 35.3%
[6] and Europe at 9.6% [5].
Recent changes in China, including economic prosperity,
environmental issues, and changes in life style such as poor diet
with more fat and sugar have been documented in the Chinese
literature as barriers to maintaining diabetics’ self-care regimens
[7]. Once diagnosed, adults with diabetes in China see a physician
monthly. To meet this demand, doctors throughout China see 50–
100 patients per day. Patients undergo a 3–10 min outpatient visit
and get their medications and diabetic supplies at the clinic. About
5–10% of diabetic adult outpatients at our hospital are referred to a
certiﬁed diabetes educator because they are newly diagnosed or
unable to manage basic care.
Diabetes is a major risk factor for ischemic heart disease and
stroke, the most common cause of chronic kidney disease, and a
leading cause of blindness [6,8,9]. Improvement in glycemic
control is key in preventing such complications [6]. In China among
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patients with diabetes, one-quarter receive medical treatment for
diabetes and slightly more than one-third of patients treated for
diabetes have adequate glycemic control [3]. Effective glycemic
control cannot be assured through medications alone. Health
promotion is essential, yet behavior change is not automatic [10].
Quality care managers and nurses in China identiﬁed health
care-related factors (such as lack of team management and
ongoing support), and patient-related factors (such as lack of
adherence by patients to regular follow-up care and to self-care)
that lead to poor glycemic control [11]. Clearly, adults with
diabetes in China need a long-term self-care plan [12]. One strategy
that can be used by diabetes educators is an individually-focused
case management approach in outpatient settings to increase the
intensity of diabetic education and psychosocial support.
The purpose of this study is to examine the effect of case
management on the primary outcome of HbA1c and secondary
outcomes of self-care behavior (diet, exercise, blood glucose
monitoring, foot care, and medication taking) and empowerment
ability in adults with Type 2 diabetes in China. Empowerment
ability refers to being able to handle psychosocial adjustments
related to problems caused by diabetes [13].
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the patients spent 15–30 min at a monthly visit, only the content
(presence of the intervention) was different between the groups. In
the second year, all the patients spent 15–30 min at visits every
3 months and both the content (without intervention) and the time
were the same for the patients in the two groups.
Study recruitment in the area surrounding one hospital in
Eastern China occurred through ﬂyers at community health
centers, recruitment posters, and announcements at diabetic
lectures. The study protocol was approved by the hospital
Institutional Review Board, and the process was in accordance
with the revised Declaration of Helsinki. Participants provided
written informed consent.
Two hundred volunteers were screened to determine eligibility.
Adults with a diagnosis of Type 2 diabetes [7,14] for 3 months,
aged 19–80 years and with ability to care for themselves were
included. Exclusion criteria were pregnancy or concurrent diseases
(including myocardial infarction, malignancy, serious neurological
or psychiatric disorders, severe infections, or organ failure).
Participants were enrolled in the study from April 2012 to February
2013. For safety purposes, each participant received basic diabetes
education when they were enrolled. Furthermore, all patients
received usual medical care.

2. Methods
2.1. Design and participants
This study was a two-arm, parallel, randomized control trial
examining the effect of case management. Participants with Type
2 diabetes were randomized to the case management (CM) group
or the control group based on random numbers generated through
Proc Plan (SAS9.2) and block randomization procedures with a
block size of 4. This process was accomplished by a statistician with
no clinical involvement in the trial, and the process was concealed
from the researchers. Group assignment for each participant was
pulled from a sequentially numbered, opaque, sealed and stapled
envelope. Blinding was not possible. One certiﬁed diabetes
educator executed the protocol for the CM group; another was
responsible for the protocol in the control group. The primary
outcome was HbA1c and the secondary outcomes were behavioral
(self-care and empowerment ability).
Participants in both groups got an equal number of study visits,
to control for attention. Speciﬁcally, during the ﬁrst 12 months, all

2.1.1. The case management intervention occurs in the ﬁrst 12 months
The patient-centered CM intervention was a systematic,
evidence-based protocol focused on diabetes-related health
behavior change [15]. It was individually tailored, initially
according to the participant’s pre-existing lifestyle habits and
preferences, and later according to answers to a standard set of
questions at monthly visits. Teaching the participant how to use
blood glucose testing data to adjust diet, exercise, and medication
taking to achieve goals was implemented according to Chinese
clinical guidelines [7].
The process of behavior change used for the CM group is
presented in Fig. 1. The diabetes educator assessed the participant’s
health care needs. Next, she discussed initial behavior change
plans, focusing on the most important barriers to disease control.
She gave sufﬁcient information, suggested strategies for change,
and answered questions to help participants (a) make decisions
related to self-care or managing diabetes-related problems and (b)
apply strategies to self-care at home. An individualized action plan
was created by the diabetes educator and the participant. Goals

Assess the participant’s health care needs

Discuss initial behavior change plans, set goals with the
participant, and develop an action plan

Modify the goals and action
plan:
1)
2)

3)

Identify the barriers with the
participant
Discuss the barriers with the
participant to see what solutions
are best to overcome the barriers
Set new goals and modify the
action plan with the participant

Did not achieve
the goals

Meet with the
participant monthly

Evaluate achievement of
individualized goals

Set new goals
and modify the
action plan

Achieved
the goals

Fig. 1. Process of behavior change used for participants in the case management group in the ﬁrst 12 months.
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were set for dietary changes, physical exercise, and self-monitoring.
The diabetes educator and the participant met face-to-face
monthly to assess difﬁculties toward achieving lifestyle modiﬁcation goals and to detect emerging problems in implementing the
care plan. Participants’ diabetes self-care regimens were evaluated
with a standard set of questions: (1) How often did you go to the
hospital to see the doctor? (2) What kind of medication do you use
now? (3) Have you checked your blood glucose, BP, weight, HbA1c,
and lipid levels? What were the results? (4) How often did you
exercise? (5) Have you suffered from hypoglycemia this month?
How did you deal with it? If the participant met the individualized
goals, the diabetes educator and participant set new goals and
modiﬁed the action plan. If participants did not, the educator
helped the patient identify barriers and ﬁnd solutions.
The diabetes educator updated the participant’s progress
monthly in the research record during the 12-month intervention.
If necessary, participants were referred short-term to a doctor, a
nutritionist, or psychologist who provided feedback to the diabetes
educator through a case report form. This referral was recorded in
the medical record.
2.1.2. The control condition in the ﬁrst 12 months
In the control group, the diabetes educator met with the
participants monthly to go through the same standard set of
questions that was used with the CM group. The control group
received no CM intervention. If a participant asked questions about
how to deal with diabetes, she did not give this information and
asked the participant to talk with his/her doctor about these
questions.
2.1.3. The follow-up from 12 to 24 months
In the second year, neither group received an intervention. All
participants visited with the same designated diabetes educator
every three months. Both groups were asked the same questions as
in the ﬁrst 12 months, except that the time frame in the second
year was every 3 months.

2.2. Outcome measures
The primary outcome measure, HbA1c, was measured by highperformance liquid chromatography. Self-care behavior was
measured using the Chinese version of the Summary of Diabetes
Self-care Activities (SDSCA) Scale [16], which is from a revised
version by Toobert et al. [17]. The 11-item scale, used to measure
the frequency of performing diabetes self-care behaviors in the last
7 days, has ﬁve dimensions: diet, exercise, blood glucose testing,
foot care, and medication taking. The Cronbach’s a is 0.62, and the
test–retest reliability is 0.83 [16]. In the current study, the
Cronbach’s a is 0.79. Empowerment ability was measured using
the Chinese version of the Diabetes Empowerment Scale-Short
Form (DES-SF) [18]. The 8-item scale uses a Likert scale (not agreealways agree). The Cronbach’s a is 0.85, and the test–retest
reliability is 0.82 [19]. In the current study, the Cronbach’s a is 0.82.
2.3. Data collection
Data were collected by the diabetes educators, one assigned to
the CM and one assigned to the control group. In the ﬁrst year, data
on demographics and clinical variables from the medical record
about treatment, medication use, and co-morbidities were
obtained at baseline. In all participants, HbA1c was measured at
baseline, 6, 12, and 24 months and self-care and empowerment
ability were measured at baseline and 12 months.
2.4. Data analysis
The sample size calculation considered a HbA1c reduction of
0.89% [20] in the CM group vs. the control group with a standard
deviation for HbA1c of 1.6 and a statistical power of 80% (a = 0.05).
To this end, the study required 52 participants per group. A sample
size of 60 participants per group (120 total) was needed in
anticipation of a 15% dropout rate.
For demographic variables, categorical data were analyzed
using frequencies and percentages as well as chi-square tests;

Enrollment (n=120)

Randomization

Allocated to the control group (n=60)

Allocated to the CM group (n=60)

Follow-up

Did not complete 12 month visit
(n=7)

Did not complete 12 month visit
(n=5)

Lost to follow-up (n=3)
Voluntary withdrawal (n=2)
Medical disqualification (n=2)

Lost to follow-up (n=3)
Voluntary withdrawal (n=1)
Deceased (n=1)

Analysis

Final CM group (n=55)

Final control group (n=53)
Fig. 2. CONSORT ﬂow diagram.
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continuous data were reported as means (standard deviation)
and compared using the independent sample t-test. For the
primary outcome, HbA1c, a mixed model was used after adjusting
for baseline HbA1c, treatment group, time, and the interaction of
group  time; 95% conﬁdence intervals of the differences are
provided.
For secondary outcomes, a paired t-test was used for withingroup comparisons; between-group differences in the treatment
effect were analyzed using an ANOVA test together with 95%
conﬁdence intervals. A chi-square test was used to analyze the
HbA1c (good  7.0% vs. poor > 7.0%) between the groups at the end
of the follow-up period at 24 months [7]. All analysis was
performed by SPSS version 16.0 software. A two-sided P-value of
0.05 was considered statistically signiﬁcant.

Table 2 details the changes in HbA1c from 6 to 24 months.
Results shows that HbA1c was signiﬁcantly (P = 0.034) reduced in
the CM group compared to the control group at 6 months
compared to baseline with a least mean of 0.43 (95% CI:
0.83, 0.03). This pattern persisted at 12 months and 24 months
but did not achieve statistical signiﬁcance ( 0.32 (95% CI: 0.70,
0.06), P = 0.094; 0.32 (95% CI: 0.79, 0.14), P = 0.167, respectively).
Using good and poor categories for HbA1c, the percentage of
participants whose HbA1c was good at 7.0% was higher over time
in the CM group (45.5% at baseline, 54.5% at 6 months, 60.0% at
12 months, and 61.8% at 24 months). At the 24-month time point,
the percentage of the participants whose HbA1c was 7.0% was
higher in the CM group than in the control group (61.8% vs. 41.5%,
P = 0.035).

3. Results

3.3. Changes in self-care behavior and empowerment ability

3.1. Baseline characteristics and drop out

Behavioral outcomes did not differ signiﬁcantly between
groups at baseline. Self-care behavior (total, exercise, blood
glucose testing, and foot care) was improved (P < 0.001) in the
CM group vs. the control group at 12 months compared to baseline
(Table 3). Within the CM group, self-care behavior total score as
well as diet, exercise, foot care, and medication taking subscales
were improved (P < 0.05) between baseline and 12 months. Within
the control group, blood glucose testing and foot care subscales
were improved (P < 0.05) between baseline and 12 months.
Empowerment ability was improved (P < 0.05) in the CM group
vs. the control group for the total score and the items about turning
diabetes goals into a workable plan, and trying different ways to
overcome barriers to attain diabetes goals at 12 months compared
to baseline. Within the CM group, empowerment ability was
enhanced (P < 0.01) for the total score and the items about
dissatisfaction with parts of diabetes care, positive ways to cope,
asking for support, and diabetes care choices between baseline and
12 months. Within the control group, participants’ empowerment
ability was enhanced (P < 0.05) for the total score and for items
about dissatisfaction with parts of diabetes care and staying
motivated to care for the diabetes between baseline and 12 months
(Table 4).

A total of 120 participants were enrolled in the study and were
randomly assigned to the intervention group (n = 60) or the control
group (n = 60). By the end of the study, 5 participants withdrew
from the CM group and 7 participants from the control group
(Fig. 2). The demographic characteristics and clinical valuables are
presented in Table 1. For the overall sample, the mean age was
58.7 years, on average they had a normal BMI, lipid proﬁle and
blood pressure, and a mean duration of diabetes of 7.5 years. About
96% of participants in both groups had health insurance. No
difference was apparent in education level between groups. The
two groups did not differ signiﬁcantly at baseline (Table 1).
3.2. Changes in glycemic control
HbA1c at different time points is presented in Fig. 3. At baseline,
there was no difference between the groups (7.75  1.52 vs.
7.44  1.66, P = 0.312). Overall, we did not ﬁnd a statistically
signiﬁcant difference between the two groups through 24 months
(P = 0.6705) or an interaction of group  time (P = 0.1609), however,
a signiﬁcant time effect was observed (P = 0.0007).
Table 1
Demographic characteristics and clinical variables at baseline.
Variable

CM group (n = 55)

Control group (n = 53)

Gender, n (%)
Male
Female

23 (41.8)
32 (58.2)

28 (52.8)
25 (47.2)

Diagnosis of hypertension, n (%)
Yes
No

23 (41.8)
32 (58.2)

22 (41.5)
31 (58.5)

Diagnosis of hyperlipidemia, n (%)
Yes
No

15 (27.3)
40 (72.7)

19 (35.9)
34 (64.1)

Diabetes medication modalities, n (%)
Oral agents
Insulin
Oral and insulin
None

23 (41.8)
9 (16.4)
19 (34.5)
4 (7.3)

21 (39.6)
5 (9.4)
25 (47.2)
2 (3.8)

Age
Duration of diabetes (years)
BMI (kg/m2)
TG (mmol/l)
HDL (mmol/l)
LDL (mmol/l)
SBP (mmHg)
DBP (mmHg)

58.35  12.34
7.08  6.95
24.49  3.49
1.55  1.17
1.27  0.31
2.91  0.93
134.53  17.33
81.16  8.43

59.04  10.67
7.94  5.69
24.55  3.24
1.71  1.70
1.29  0.47
2.87  0.91
130.25  19.66
79.10  10.52

P
0.335

1.000

0.409

0.848
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Fig. 3. Mean HbA1c for the intervent ion (CM) and control groups at each study time period. No statistical signiﬁcance between the two groups through 24 months (P = 0.605)
and interaction of group  time (P = 0.1609). Signiﬁcant time effect between two groups (P = 0.0007).

Table 2
Comparison of reduction of HbA1c from baseline between the groups.
Variable
6 months, %
12 months, %
24 months, %
a

CM group (n = 55)
Mean  SD

Group Difference (95% CI)a

Control group (n = 53)
Mean  SD

0.55  1.34
0.71  1.23
0.59  1.70

0.06  1.44
0.20  1.40
0.08  1.44

P

0.43 ( 0.83, 0.03)
0.32 ( 0.70, 0.06)
0.32 ( 0.79, 0.14)

0.034
0.094
0.167

Adjusted baseline HbA1c, group, time, group  time.

Table 3
Self-care behavior between the groups.
Item

Total score
Diet
Exercise
Blood glucose testing
Foot care
Medication taking
a
b

CM group (n = 55) Mean  SD

Control group (n = 53) Mean  SD

Baseline

12 m

Baseline

12 m

48.89  16.55
18.87  7.16
10.31  4.72
4.07  4.04
9.00  5.61
5.87  2.53

58.58  8.62b
22.72  4.56b
12.45  2.26b
3.57  2.92
13.17  2.68b
6.68  1.24a

44.69  14.68
19.14  7.34
8.42  4.92
2.26  2.15
7.72  6.05
6.26  1.93

45.98  18.22
19.36  8.45
9.30  4.74
1.20  1.11b
9.28  5.03a
5.92  2.45

Group difference (95% CI)

P

8.40 (4.28, 12.52)
1.54 ( 0.38, 3.46)
2.52 (1.35, 3.70)
2.09 (1.22, 2.96)
2.58 (1.21, 3.96)
0.18 ( 0.39, 0.76)

<0.001
0.114
<0.001
<0.001
<0.001
0.528

Within-group comparison, P < 0.05.
Within-group comparison, P < 0.01.

4. Discussion and conclusion
4.1. Discussion
Study results support the effectiveness of a case management
intervention in reducing HbA1c in one hospital outpatient setting
in China. Although recent (2006 and 2010) meta-analyses in the
literature support case management [20,21], this approach in the
care of adult diabetics is introduced in a review in 2013 in China
[22]. Although several reports were published about case
management in China in the nearly two years, these studies were
different from ours: the duration of the intervention was shorter
and the outcome measures were different, and behavior change
was not the focus [23,24]. Therefore, the current study extends the
literature on case management in China by taking a longer-term,
more comprehensive approach to providing information and skills,
and helping adults enhance their own innate ability to attain their
diabetes goals.
Diabetes educators in China were used to using a “teach to” and
“I know the right thing for you” approach which were found to be
generally ineffective [11]. The case management approach

developed for the current study was adapted to Chinese contexts.
We set goals with the patients (not for the patients), referred to the
Chinese guidelines when setting up the education portion and
metabolic control targets for patients, and aligned the intervention
with habits (diet, exercise) of Chinese people.
Interventions implemented at our setting are feasible largely
because the diabetes education clinics are well established in our
hospital and the clinics are a frequent site for a variety of research
studies. When tested at the onset of the study, we found this
study’s protocol to be feasible. It is likely that the individualized
approach used in this study was easier for participants to accept.
Using blood glucose testing data to adjust diet, exercise, and
medication taking was important and well-received by participants
In the current study, the reduction of HbA1c in the CM group
compared with the control group was signiﬁcant at 6 months, with
trends observed at 12 months and 24 months. These results agree
with studies in other countries that found an improvement in
HbA1c after case management interventions [20,21,25]. The
reduction of HbA1c after case management over a 24-month
period in the current study is similar to recent ﬁndings of Hsu et al.
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0.025
0.057
0.004
0.016
0.187
0.860
0.143
0.473
0.541

[25], although those authors provided the intervention for a longer
time, over a 36-month period.
Recent clinical guidelines support lowering HbA1c to 7% or less
to reduce microvascular complications of diabetes [12]. At the 24month time point, the percentage of the participants whose HbA1c
was 7.0% was signiﬁcantly higher in the CM group than in the
control group, indicating a clinically meaningful ﬁnding of more
successful glycemic control in the CM group at the end of the study.
The current study demonstrated that case management led to
signiﬁcant improvements in the secondary outcomes. Participants’
total self-care behaviors and also diet, exercise, blood glucose
testing, and foot care were signiﬁcantly improved in the CM group
vs. the control group at 12 months. These ﬁndings agree with Shin
et al. [26], and Chang et al. [27] who reported positive self-care
behavior changes 1 year after case management.
Given the large numbers of patients seen by the Chinese health
care system each day, it is imperative that diabetic adults (a) have
the appropriate skill set to manage psychosocial adjustments
related to problems caused by diabetes, and (b) have support to
help them adjust daily to their diabetes within their lifestyle and
environmental situation. Based on the Empowerment measure,
participants in CM group reported that they were able to turn
diabetes goals into a workable plan and could try out different
ways to overcome barriers to attain diabetes goals, compared with
the control group. Higher empowerment ability is desirable
because, in that case, patients had an enhanced capacity to accept
responsibility for their behavior change. Moreover, empowerment
ability has been found in the literature to be a signiﬁcant predictor
of self-care behavior and HbA1c [28].
The study has several limitations. First, this study was
conducted at one hospital in China and lacked blinding. Second,
this study did not analyze health care cost, because of incomplete
data. Third, due to time factors, we did not measure participants’
self-care behavior and empowerment ability at 24 months. Finally,
just the mere action of asking questions could be interpreted as a
mild intervention in itself, as it might have raised patients’
awareness of topics that were important. This could be a factor
which might account for changes observed in the control group. A
strength of the current study is the lack of attrition during the
follow-up period. Another strength is the study’s feasibility. Finally
the CM intervention may have been successful because of its
intense focusing on the participant, and on the individualization of
care.











12 months

35.33
4.49
4.10
4.18
4.31
4.31
4.55
4.76
4.63









33.96
4.12
4.04
4.10
4.33
4.16
4.43
4.55
4.59
2.94b
0.50b
0.69
0.72
0.50
0.57b
0.43b
0.50
0.43b









36.85
4.72
4.42
4.45
4.57
4.42
4.75
4.79
4.75

4.2. Conclusion

b

Within-group comparison, P < 0.05.
Within-group comparison, P < 0.01.

The case management intervention in China was effective at
6 months and, based on trends in HbA1c at 12 and 24 months and
results in self-care behavior, shows promise and warrants more
research. This study provides valuable information to guide
diabetes educators in using case management to promote better
control of HbA1c and self-behavior change for people with Type
2 diabetes.

a

Total score
Know what part(s) of taking care of my diabetes that I am dissatisﬁed with
Be able to turn my diabetes goals into a workable plan
Can try out different ways of overcoming barriers to my diabetes goals
Can ﬁnd ways to feel better about having diabetes
Know the positive ways I cope with diabetes-related stress
Can ask for support for having and caring for my diabetes when I need it
Know what helps me stay motivated to care for my diabetes
Know enough about myself as a person to make diabetes care choices that are right for me

34.72
4.26
4.33
4.31
4.33
4.02
4.46
4.62
4.37











4.10
0.73
0.78
0.72
0.85
0.91
0.61
0.53
0.73

12months

4.18
0.88
0.82
0.77
0.80
0.75
0.71
0.68
0.61
Baseline
Baseline

3.07b
0.55b
0.65
0.60
0.68
0.59
0.54
0.43a
0.49

1.14 (0.14, 2.14)
0.18 ( 0.005, 0.37)
0.30 (0.10, 0.51)
0.24 (0.05, 0.44)
0.13 ( 0.07, 0.33)
0.02 ( 0.22, 0.18)
0.12 ( 0.04, 0.28)
0.05 ( 0.09, 0.20)
0.05 ( 0.21, 0.11)

P
Difference (95% CI)
Control group (n = 53) Mean  SD
CM group (n = 55) Mean  SD
Item

Table 4
Empowerment ability between the groups.
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4.3. Practice implications
In China currently, doctors do not have enough time to educate
people with diabetes. The diabetes educator, using a case
management approach, can help overcome this limitation. Due
to the high prevalence of Type 2 diabetes and prediabetes in China
and the low numbers of certiﬁed diabetes educators, there is a
great need for future research on what timing and length of
program are most effective. Case management may lead to
improved quality of care, but quality processes and outcomes
must be studied. Attention must be focused on the sustainability of
the effects of case management over time. Due to the labor
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intensity of a 1-year CM intervention and the need for many
patients to be seen by the diabetes educators, perhaps a shorter
three-month CM intervention might be considered on a long-term
basis in the clinic; its clinical effectiveness would need to be
determined.
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